NX-1607NX-1607-enhancedCasitas B lymphoma-b
…highlighting its potential as a promising immunotherapy target. NX-1607 is the first oral small molecule inhibitor of Cbl-b and it is c…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: NX-1607-enhanced ×
NX-1607-enhanced
This drug is selected. Its supporting articles are shown below.